… for the front-line management of adult patients with an established diagnosis of post-transplant
lymphoproliferative disorder (PTLD) following solid organ transplantation (SOT). …

… analyzed outcomes in 67 adult solid organ transplant PTLD patients managed with a …
We recommend rituximab monotherapy as the next level of treatment for adult and pediatric …

… Post-transplant lymphoproliferative disorder (PTLD) includes a broad and heterogeneous
group of disorders, ranging from indolent and non-malignant lymphoproliferations to malignant …

… We further analyze common treatment strategies and … Post-transplant lymphoproliferative
disorder (PTLD) is the most common malignancy in recipients of solid organ transplantation (…

… subset, which included a significant proportion of adolescents and young adults with …
Management of Epstein–Barr Virus infections and post-transplant lymphoproliferative disorders in …

… PTLDs are seen after both solid organ and hematopoietic stem cell transplants … post
transplant lymphomas over the years has considerably improved the diagnosis and management …

… in adult kidney (-pancreas) transplant recipients (3). The risk of developing PTLD depends on
the type of organ transplanted … caused by either disease progression or a treatment-related …

… in PTLD management, we aimed to establish a present benchmark for comparison between
international centers and between various organ transplant … and adult patient transplantation …

… Post-transplant lymphoproliferative disorders (PTLD) are one of the most important …
Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients …

… the largest and the only comprehensive adult solid-organ transplant programme in the UK. …
The risk-stratified approach has become the standard of care in the front-line management …